Varian’s Reimbursement and Market Access team is committed to keeping stakeholders engaged on important government healthcare rules and regulations guiding radiation oncology. Below, the team provides summaries and updates related to Medicare policy announcements and other relevant content for our U.S. clinical partners. The content on this site is not intended to serve as legal or reimbursement advice.


The information provided herein has been gathered from third-party sources which include, but are not limited to government and commercially available coding guides, professional societies, and research conducted by coding and reimbursement consultants, and is subject to change without notice because of complex and frequently changing laws, regulations, rules, and policies.

*This information should not be construed as authoritative and is presented for illustrative and informational purposes only. It does not constitute either reimbursement or legal advice. The entity billing Medicare, other government programs and/or third-party payers is solely responsible for determining medical necessity, the proper site for delivery of any services, and submitting accurate and appropriate codes, charges, and modifiers for services that are rendered and reflected in a patient’s medical record. Varian does not have access to medical records, and therefore cannot recommend codes for specific cases. Varian recommends that you consult with your payers, reimbursement specialists and/or legal counsel regarding coding, coverage, and reimbursement matters. Varian’s products have been cleared for use by the FDA as set forth in our Instructions for Use and nothing in this document should be construed as promoting any use outside of those instructions.